PHENYLephrine Intravenous Bags Recalled for Lack of Sterility Assurance
Central Admixture Pharmacy Services is recalling PHENYLephrine IV bags distributed nationwide. The company could not prove the products were properly sterilized.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall involving an intravenous medication with no reported illnesses or injuries. However, it represents a risk-of-harm product where sterility failure could potentially cause serious infections. The recall is precautionary, based on lack of validation data rather than confirmed contamination.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling PHENYLephrine 10mg/250ml added to 0.9% sodium chloride IV bags (40mcg/mL concentration). Approximately 7,518 bags across multiple lot numbers with expiration dates from July through September 2023 are affected by this nationwide recall.
The recall was initiated because there is a lack of assurance of sterility. Specifically, the manufacturer did not provide sufficient validation data for the decontamination cycles used in the manufacturing process.
Healthcare facilities that have received these products should identify affected lot numbers and consult with their pharmacy director for guidance. Patients should discuss any concerns about their medications with their healthcare provider.
The recalled product
- Product
- PHENYLephrine, 10mg/250ml added to 0.9% sodium chloride, 40mcg/mL, IV Bag, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-6058-1.
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug — Intravenous
- Affected units
- 7,518
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot: 36-239333
- Exp. 7/11/2023
- 36-240005
- Exp. 7/13/2023
- 36-240800
- Exp. 7/17/2023
- 36-241139
- 36-241140
- Exp. 7/19/2023
- 36-241913
- Exp.7/23/2023
- 36-242557
- 36-242560
- Exp. 7/25/2023
- 36-244880
- 36-244883
- 36-244884
- 36-244885
- Exp. 8/1/2023
- 36-246717
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 95 recalled by Central Admixture Pharmacy Services, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 95 products in this recall →Related recalls
Same manufacturer · Central Admixture Pharmacy Services, Inc.
See all →- ModeratePediatric TPN Bags Recalled for Incorrect Formulation
FDA (Drugs) · 2026-08-12
- SeverePediatric Total Parenteral Nutrition Bag Recalled for Incorrect Formulation
FDA (Drugs) · 2026-07-01
- SevereInjectable Phenylephrine Solution Recalled Due to Particulate Matter Contamination
FDA (Drugs) · 2025-03-19
- HighInjectable Lidocaine Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-10-11
- HighMidazolam Injectable Solution Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2023-10-11
Same hazard · contamination risk
See all →- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Vancomycin Injection Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- HighIntramedullary Bone Saw Blade Assembly Recall for Packaging Damage
FDA (Devices) · 2026-08-12
- SevereMedical Convenience Kits Recalled Over Lidocaine Injection Supplier Quality Issues
FDA (Devices) · 2026-08-05